Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 564573, 21 pages
http://dx.doi.org/10.1155/2014/564573
Research Article

Significance of Algal Polymer in Designing Amphotericin B Nanoparticles

1PDMCOP, Bahadurgarh, Haryana 124507, India
2Department of Pharmaceutical Sciences, Jamia Hamdard, New Delhi 110062, India
3School of Pharmacy, Faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
4Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India

Received 7 July 2014; Revised 1 September 2014; Accepted 15 September 2014; Published 12 November 2014

Academic Editor: Rizwan Hasan Khan

Copyright © 2014 Saurabh Bhatia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. Torrado, R. Espada, M. P. Ballesteros, and S. Torrado-Santiago, “Amphotericin B formulations and drug targeting,” Journal of Pharmaceutical Sciences, vol. 97, no. 7, pp. 2405–2425, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. Hamill, “Amphotericin B formulations: a comparative review of efficacy and toxicity,” Drugs, vol. 73, no. 9, pp. 919–934, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. D. Moen, K. A. Lyseng-Williamson, and L. J. Scott, “Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections,” Drugs, vol. 69, no. 3, pp. 361–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Datta and T. Bera, “The effects of clofazimine, niclosamide and amphotericin B, on electron transport of Leishmania donovani promastigotes,” Indian Journal of Medical Research, vol. 112, pp. 15–20, 2000. View at Google Scholar · View at Scopus
  5. R. Espada, S. Valdespina, C. Alfonso, G. Rivas, M. P. Ballesteros, and J. J. Torrado, “Effect of aggregation state on the toxicity of different amphotericin B preparations,” International Journal of Pharmaceutics, vol. 361, no. 1-2, pp. 64–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. H. Hamman, “Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems,” Marine Drugs, vol. 8, no. 4, pp. 1305–1322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Muller, “Shaping and pharmaceutical applications of polyelectrolyte complex nanoparticles,” Advances in Polymer Science, vol. 264, pp. 1–64, 2012. View at Google Scholar
  8. I. Gruda, D. Milette, M. Brother, G. S. Kobayashi, G. Medoff, and J. Brajtburg, “Structure-activity study of inhibition of amphotericin B (fungizone) binding to sterols, toxicity to cells, and lethality to mice by esters of sucrose,” Antimicrobial Agents and Chemotherapy, vol. 35, no. 1, pp. 24–28, 1991. View at Publisher · View at Google Scholar · View at Scopus
  9. A. B. Mullen, K. C. Carter, and A. J. Baillie, “Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 10, pp. 2089–2092, 1997. View at Google Scholar · View at Scopus
  10. F. Gaboriau, M. Chéron, C. Petit, and J. Bolard, “Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 11, pp. 2345–2351, 1997. View at Google Scholar · View at Scopus
  11. M. A. Ghannoum and L. B. Rice, “Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance,” Clinical Microbiology Reviews, vol. 12, no. 4, pp. 501–517, 1999. View at Google Scholar · View at Scopus
  12. M. L. Adams, D. R. Andes, and G. S. Kwon, “Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity,” Biomacromolecules, vol. 4, no. 3, pp. 750–757, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S. H. Jung, D. H. Lim, J. E. Lee, K.-S. Jeong, H. Seong, and B. C. Shin, “Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics,” European Journal of Pharmaceutical Sciences, vol. 37, no. 3-4, pp. 313–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Gharib, Z. Faezizadeh, and H. Mohammad Asghari, “Preparation and antifungal activity of spray-dried amphotericin B-loaded nanospheres,” DARU, Journal of Pharmaceutical Sciences, vol. 19, no. 5, pp. 351–355, 2011. View at Google Scholar · View at Scopus
  15. J. Rebello, M. Ohno, H. Ukeda, H. Kusunose, and M. Sawamura, “3,6 anhydrogalactose, sulfate and methoxyl contents of commercial agarophytes from different geographical origins,” Journal of Applied Phycology, vol. 9, no. 4, pp. 367–370, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Tuvikene, K. Truus, A. Kollist, O. Volobujeva, E. Mellikov, and T. Pehk, “Gel-forming structures and stages of red algal galactans of different sulfation levels,” Journal of Applied Phycology, vol. 20, no. 5, pp. 527–535, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Genicot-Joncour, A. Poinas, O. Richard et al., “The cyclization of the 3,6-anhydro-galactose ring of I-carrageenan is catalyzed by two D-galactose-2,6-sulfurylases in the red alga Chondrus crispus,” Plant Physiology, vol. 151, no. 3, pp. 1609–1616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Nagpal, S. K. Singh, and D. N. Mishra, “Chitosan nanoparticles: a promising system in novel drug delivery,” Chemical and Pharmaceutical Bulletin, vol. 58, no. 11, pp. 1423–1430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Bhatia, K. Sharma, A. G. Namdeo, B. B. Chaugule, M. Kavale, and S. Nanda, “Broad-spectrum sun-protective action of Porphyra-334 derived from Porphyra vietnamensis,” Pharmacognosy Research, vol. 2, no. 1, pp. 45–49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Bhatia, A. Sharma, K. Sharma et al., “Novel algal polysaccharides from marine source: porphyran,” Pharmacognosy Review, vol. 2, pp. 271–276, 2008. View at Google Scholar
  21. S. Bhatia, A. G. Namdeo, and S. Nanda, “Factors effecting the gelling and emulsifying properties of a natural polymer,” Systematic Reviews in Pharmacy, vol. 1, no. 1, pp. 86–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Bhatia, P. Rathee, K. Sharma, B. B. Chaugule, N. Kar, and T. Bera, “Immuno-modulation effect of sulphated polysaccharide (porphyran) from Porphyra vietnamensis,” International Journal of Biological Macromolecules, vol. 57, pp. 50–56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Takahashi, Y. Hirano, S. Araki, and M. Hattori, “Emulsifying ability of porphyran prepared from dried nori, Porphyra yezoensis, a red alga,” Journal of Agricultural and Food Chemistry, vol. 48, no. 7, pp. 2721–2725, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Tiyaboonchai, J. Woiszwillo, and C. R. Middaugh, “Formulation and characterization of amphotericin B-polyethylenimine-dextran sulfate nanoparticles,” Journal of Pharmaceutical Sciences, vol. 90, no. 7, pp. 902–914, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Tiyaboonchai and N. Limpeanchob, “Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles,” International Journal of Pharmaceutics, vol. 329, no. 1-2, pp. 142–149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. B. Vieira and A. M. Carmona-Ribeiro, “Cationic nanoparticles for delivery of amphotericin B: Preparation, characterization and activity in vitro,” Journal of Nanobiotechnology, vol. 6, article 6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Rodrigues, A. M. R. da Costa, and A. Grenha, “Chitosan/carrageenan nanoparticles: effect of cross-linking with tripolyphosphate and charge ratios,” Carbohydrate Polymers, vol. 89, no. 1, pp. 282–289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. L. C. da Silva, T. Garcia, M. Mori et al., “Preparation and characterization of polysaccharide-based nanoparticles with anticoagulant activity,” International Journal of Nanomedicine, vol. 7, pp. 2975–2986, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Nagpal, S. K. Singh, and D. N. Mishra, “Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety,” International Journal of Biological Macromolecules, vol. 59, pp. 72–83, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Nagpal, S. K. Singh, and D. N. Mishra, “Formulation, optimization, in vivo pharmacokinetic, behavioral and biochemical estimations of minocycline loaded chitosan nanoparticles for enhanced brain uptake,” Chemical and Pharmaceutical Bulletin, vol. 61, no. 3, pp. 258–272, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Ishihara, C. Oyamada, R. Matsushima, M. Murata, and T. Muraoka, “Inhibitory effect of porphyran, prepared from dried “Nori”, on contact hypersensitivity in mice,” Bioscience, Biotechnology and Biochemistry, vol. 69, no. 10, pp. 1824–1830, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  33. M. Dubois, K. Gilles, J. K. Hamilton, P. A. Rebers, and F. Smith, “A colorimetric method for the determination of sugars,” Nature, vol. 168, no. 4265, p. 167, 1951. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Guerrini, A. Mazzotti, L. Boni, and R. Pistocchi, “Bacterial-algal interactions in polysaccharide production,” Aquatic Microbial Ecology, vol. 15, no. 3, pp. 247–253, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Yaphe and G. P. Arsenault, “Improved resorcinol reagent for the determination of fructose, and of 3,6-anhydrogalactose in polysaccharides,” Analytical Biochemistry, vol. 13, no. 1, pp. 143–148, 1965. View at Publisher · View at Google Scholar · View at Scopus
  36. H. B. Nader and C. P. Dietrich, “Determination of sulfate after chromatography and toluidine blue complex formation,” Analytical Biochemistry, vol. 78, no. 1, pp. 112–118, 1977. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Leo, R. Cameroni, and F. Forni, “Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates,” International Journal of Pharmaceutics, vol. 180, no. 1, pp. 23–30, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Torrado, P. Prada, and P. M. de La Torre, “Chitosan-poly(acrylic) acid polyionic complex: In vivo study to demonstrate prolonged gastric retention,” Biomaterials, vol. 25, no. 5, pp. 917–923, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. A. K. Chhillar, P. Arya, C. Mukherjee et al., “Microwave-assisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones: novel compounds against aspergillosis,” Bioorganic & Medicinal Chemistry, vol. 14, no. 4, pp. 973–981, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. A. K. Singhai, S. Jain, and N. K. Jain, “Evaluation of an aqueous injection of ketoprofen,” Pharmazie, vol. 52, no. 2, pp. 149–154, 1997. View at Google Scholar · View at Scopus
  41. M. C. G. Marcondes, P. Borelli, N. Yoshida, and M. Russo, “Acute Trypanosoma cruzi infection is associated with anemia, thrombocytopenia, leukopenia, and bone marrow hypoplasia: reversal by nifurtimox treatment,” Microbes and Infection, vol. 2, no. 4, pp. 347–352, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Zhao, Q. Zhang, H. Qi et al., “Degradation of porphyran from Porphyra haitanensis and the antioxidant activities of the degraded porphyrans with different molecular weight,” International Journal of Biological Macromolecules, vol. 38, no. 1, pp. 45–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Yardley and S. L. Croft, “In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections,” The American Journal of Tropical Medicine and Hygiene, vol. 61, no. 2, pp. 193–197, 1999. View at Google Scholar · View at Scopus
  44. K. H. Seol, D. G. Lim, A. Jang, C. Jo, and M. Lee, “Antimicrobial effect of κ-carrageenan-based edible film containing ovotransferrin in fresh chicken breast stored at 5°C,” Meat Science, vol. 83, no. 3, pp. 479–483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Vera, J. Castro, A. Gonzalez, and A. Moenne, “Seaweed polysaccharides and derived oligosaccharides stimulate defense responses and protection against pathogens in plants,” Marine Drugs, vol. 9, no. 12, pp. 2514–2525, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. R. M. Cooper and J. S. Williams, “Elemental sulphur as an induced antifungal substance in plant defence,” Journal of Experimental Botany, vol. 55, no. 404, pp. 1947–1953, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Groth, N. Grünewald, and S. Alban, “Pharmacological profiles of animal- and nonanimal-derived sulfated polysaccharides—comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguinea,” Glycobiology, vol. 19, no. 4, pp. 408–417, 2009. View at Publisher · View at Google Scholar · View at Scopus